Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 15 studies | 33% ± 14% | |
| peripheral blood | 15 studies | 28% ± 10% | |
| intestine | 9 studies | 29% ± 13% | |
| kidney | 8 studies | 31% ± 7% | |
| eye | 6 studies | 28% ± 13% | |
| brain | 6 studies | 22% ± 6% | |
| liver | 6 studies | 33% ± 23% | |
| pancreas | 5 studies | 42% ± 16% | |
| bone marrow | 5 studies | 25% ± 8% | |
| lymph node | 5 studies | 23% ± 6% | |
| placenta | 4 studies | 35% ± 23% | |
| uterus | 4 studies | 35% ± 16% | |
| breast | 4 studies | 23% ± 4% | |
| adrenal gland | 3 studies | 18% ± 2% | |
| skin | 3 studies | 19% ± 3% | |
| thymus | 3 studies | 52% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1897.30 | 1445 / 1445 | 100% | 35.51 | 183 / 183 |
| liver | 100% | 1222.05 | 226 / 226 | 100% | 33.75 | 406 / 406 |
| ovary | 100% | 1600.96 | 180 / 180 | 100% | 70.10 | 430 / 430 |
| pancreas | 100% | 909.96 | 328 / 328 | 100% | 34.00 | 178 / 178 |
| uterus | 100% | 1614.11 | 170 / 170 | 100% | 58.84 | 459 / 459 |
| brain | 100% | 1647.76 | 2640 / 2642 | 100% | 49.58 | 705 / 705 |
| breast | 100% | 1796.38 | 459 / 459 | 100% | 53.21 | 1117 / 1118 |
| lung | 100% | 1540.16 | 577 / 578 | 100% | 36.00 | 1155 / 1155 |
| bladder | 100% | 1836.10 | 21 / 21 | 100% | 54.07 | 503 / 504 |
| prostate | 100% | 1758.40 | 245 / 245 | 100% | 46.51 | 501 / 502 |
| skin | 100% | 1894.10 | 1809 / 1809 | 100% | 37.21 | 471 / 472 |
| thymus | 100% | 1881.28 | 653 / 653 | 100% | 45.58 | 603 / 605 |
| intestine | 100% | 1948.11 | 966 / 966 | 99% | 45.48 | 524 / 527 |
| kidney | 100% | 2734.00 | 89 / 89 | 99% | 29.62 | 895 / 901 |
| stomach | 100% | 1456.28 | 359 / 359 | 99% | 46.70 | 284 / 286 |
| adrenal gland | 100% | 1681.34 | 258 / 258 | 98% | 29.36 | 225 / 230 |
| adipose | 100% | 1736.66 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 26.45 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 71.04 | 29 / 29 |
| muscle | 100% | 2127.56 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1781.68 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 57.43 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 41.01 | 1 / 1 |
| blood vessel | 100% | 1811.28 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| heart | 99% | 1858.38 | 853 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 44% | 905.95 | 409 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0000398 | Biological process | mRNA splicing, via spliceosome |
| GO_0033962 | Biological process | P-body assembly |
| GO_0006397 | Biological process | mRNA processing |
| GO_0000932 | Cellular component | P-body |
| GO_0046540 | Cellular component | U4/U6 x U5 tri-snRNP complex |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0120115 | Cellular component | Lsm2-8 complex |
| GO_0071011 | Cellular component | precatalytic spliceosome |
| GO_0071013 | Cellular component | catalytic step 2 spliceosome |
| GO_0005688 | Cellular component | U6 snRNP |
| GO_1990726 | Cellular component | Lsm1-7-Pat1 complex |
| GO_0071005 | Cellular component | U2-type precatalytic spliceosome |
| GO_0005634 | Cellular component | nucleus |
| GO_0030629 | Molecular function | U6 snRNA 3'-end binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0003723 | Molecular function | RNA binding |
| Gene name | LSM3 |
| Protein name | U6 snRNA-associated Sm-like protein LSm3 |
| Synonyms | MDS017 |
| Description | FUNCTION: Plays a role in pre-mRNA splicing as component of the U4/U6-U5 tri-snRNP complex that is involved in spliceosome assembly, and as component of the precatalytic spliceosome (spliceosome B complex) . The heptameric LSM2-8 complex binds specifically to the 3'-terminal U-tract of U6 snRNA . . FUNCTION: Binds specifically to the 3'-terminal U-tract of U6 snRNA. . |
| Accessions | B2R5H5 P62310 ENST00000306024.4 |